C. Capo-chichi, K. Cai, J. Smedberg, P. Ganjei-azar, A. Godwin et al., Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer, Chinese Journal of Cancer, vol.30, issue.6, pp.415-440, 2011.
DOI : 10.5732/cjc.010.10566

D. Zink, A. Fischer, and J. Nickerson, Nuclear structure in cancer cells, Nature Reviews Cancer, vol.43, issue.9, pp.677-87, 2004.
DOI : 10.1159/000331347

V. Butin-israeli, S. Adam, A. Goldman, and R. Goldman, Nuclear lamin functions and disease, Trends in Genetics, vol.28, issue.9, pp.464-71, 2012.
DOI : 10.1016/j.tig.2012.06.001
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633455/pdf

P. Cau, C. Navarro, K. Harhouri, P. Roll, S. Sigaudy et al., Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective, Seminars in Cell & Developmental Biology, vol.29, 2014.
DOI : 10.1016/j.semcdb.2014.03.021
URL : https://hal.archives-ouvertes.fr/hal-01646524

E. Hatch, A. Fischer, T. Deerinck, and M. Hetzer, Catastrophic Nuclear Envelope Collapse in Cancer Cell Micronuclei, Cell, vol.154, issue.1, pp.47-60, 2013.
DOI : 10.1016/j.cell.2013.06.007
URL : https://doi.org/10.1016/j.cell.2013.06.007

Z. Wu, L. Wu, D. Weng, D. Xu, J. Geng et al., Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma, Journal of Experimental & Clinical Cancer Research, vol.28, issue.1, 2009.
DOI : 10.1186/1756-9966-28-8

S. Perrin, J. Cremer, O. Faucher, J. Reynes, P. Dellamonica et al., HIV Protease Inhibitors Do Not Cause the Accumulation of Prelamin A in PBMCs from Patients Receiving First Line Therapy: The ANRS EP45 ???Aging??? Study, PLoS ONE, vol.15, issue.12, pp.53035-23285253, 2012.
DOI : 10.1371/journal.pone.0053035.s005
URL : https://hal.archives-ouvertes.fr/hal-01646470

H. Jung, C. Coffinier, Y. Choe, A. Beigneux, B. Davies et al., Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA, Proceedings of the National Academy of Sciences, vol.118, issue.10, pp.423-454, 2012.
DOI : 10.1172/JCI35876

X. Nissan, S. Blondel, C. Navarro, Y. Maury, C. Denis et al., Unique Preservation of Neural Cells in Hutchinson- Gilford Progeria Syndrome Is Due to the Expression of the Neural-Specific miR-9 MicroRNA, Cell Reports, vol.2, issue.1, pp.1-9, 2012.
DOI : 10.1016/j.celrep.2012.05.015

I. Lopez-mejia, V. Vautrot, D. Toledo, M. Behm-ansmant, I. Bourgeois et al., A conserved splicing mechanism of the LMNA gene controls premature aging, Human Molecular Genetics, vol.20, issue.23, pp.4540-55, 2011.
DOI : 10.1093/hmg/ddr385

P. Scaffidi and T. Misteli, Lamin A-dependent nuclear defects in human aging. Science, pp.1059-63, 2006.
DOI : 10.1126/science.1127168
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855250/pdf

S. Das and A. Krainer, Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer, Molecular Cancer Research, vol.12, issue.9, pp.1195-204, 2014.
DOI : 10.1158/1541-7786.MCR-14-0131

S. Gout, E. Brambilla, A. Boudria, R. Drissi, S. Lantuejoul et al., Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma, PLoS ONE, vol.7, issue.10, p.23071587, 2012.
DOI : 10.1371/journal.pone.0046539.s004

Y. Tang, Y. Chen, H. Jiang, and D. Nie, Promotion of tumor development in prostate cancer by progerin, Cancer Cell International, vol.10, issue.1, pp.47-21106101, 2010.
DOI : 10.1186/1475-2867-10-47

S. Okamoto, A. Okamoto, T. Nikaido, M. Saito, M. Takao et al., Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts, Oncology Reports, vol.21, issue.5, pp.1209-1223, 2009.
DOI : 10.3892/or_00000343

X. Zhai, H. Zhu, W. Wang, S. Zhang, Y. Zhang et al., Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC, Medical Oncology, vol.176, issue.2, p.970, 2014.
DOI : 10.2353/ajpath.2010.090526

G. Liao, M. Wang, Y. Ou, and Y. Zhao, IGF-1-induced epithelial???mesenchymal transition in MCF-7 cells is mediated by MUC1, Cellular Signalling, vol.26, issue.10, pp.2131-2138, 2014.
DOI : 10.1016/j.cellsig.2014.06.004

S. Nath and P. Mukherjee, MUC1: a multifaceted oncoprotein with a key role in cancer progression, Trends in Molecular Medicine, vol.20, issue.6, pp.332-374
DOI : 10.1016/j.molmed.2014.02.007

T. Xu, X. Liu, L. Han, H. Shen, L. Liu et al., Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex, pp.469-75, 2014.

T. Gutschner, M. Hämmerle, and S. Diederichs, MALAT1 ??? a paradigm for long noncoding RNA function in cancer, Journal of Molecular Medicine, vol.157, issue.2, pp.791-801
DOI : 10.1016/S0002-9440(10)64594-4

P. Ji, S. Diederichs, W. Wang, S. Böing, R. Metzger et al., MALAT-1, a novel noncoding RNA and thymosin ??4 predict metastasis and survival in early-stage non-small cell lung cancer, Oncogene, vol.22, issue.39, pp.8031-8072, 2003.
DOI : 10.1074/jbc.274.19.13698

L. Schmidt, T. Spieker, S. Koschmieder, S. Schäffers, J. Humberg et al., The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth, Journal of Thoracic Oncology, vol.6, issue.12, pp.1984-92, 2011.
DOI : 10.1097/JTO.0b013e3182307eac

L. Shen, L. Chen, Y. Wang, X. Jiang, H. Xia et al., Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer, Journal of Neuro-Oncology, vol.9, issue.1, 2014.
DOI : 10.1371/journal.pgen.1003368

E. Leucci, F. Patella, J. Waage, K. Holmstrøm, M. Lindow et al., microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus, Scientific Reports, vol.1, issue.1, pp.2535-23985560, 2013.
DOI : 10.1038/nprot.2006.82

R. Lin, M. Roychowdhury-saha, C. Black, A. Watt, E. Marcusson et al., Control of RNA processing by a large non-coding RNA over-expressed in carcinomas, FEBS Letters, vol.24, issue.4, pp.671-677, 2011.
DOI : 10.1016/j.molcel.2010.08.011

V. Tripathi, J. Ellis, Z. Shen, D. Song, Q. Pan et al., The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation, Molecular Cell, vol.39, issue.6, 2010.
DOI : 10.1016/j.molcel.2010.08.011
URL : https://doi.org/10.1016/j.molcel.2010.08.011

D. Weber, G. Johnen, S. Casjens, O. Bryk, B. Pesch et al., Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer, BMC Research Notes, vol.6, issue.1, pp.518-24313945, 2013.
DOI : 10.1007/s00109-013-1028-y

D. Lee, J. Kang, C. Lee, S. Kim, Y. Choi et al., Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of Metastasis, Cancer Research and Treatment, vol.45, issue.2, pp.95-102
DOI : 10.4143/crt.2013.45.2.95

D. Lee, Y. Kim, C. Kay, S. Kim, C. Yeo et al., Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer, Medicine, vol.95, issue.6, p.2795
DOI : 10.1097/MD.0000000000002795

M. Kuchuk, I. Kuchuk, E. Sabri, B. Hutton, M. Clemons et al., The incidence and clinical impact of bone metastases in non-small cell lung cancer. Lung Cancer Amst Neth, pp.197-202, 2015.

G. Heller, M. Weinzierl, C. Noll, V. Babinsky, B. Ziegler et al., Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non-Small Cell Lung Cancers, Clinical Cancer Research, vol.18, issue.6, pp.1619-1648, 2012.
DOI : 10.1158/1078-0432.CCR-11-2450

A. Lujambio, G. Calin, A. Villanueva, S. Ropero, M. Sánchez-céspedes et al., A microRNA DNA methylation signature for human cancer metastasis, Proceedings of the National Academy of Sciences, vol.11, issue.11, pp.13556-61, 2008.
DOI : 10.1261/rna.2148705
URL : http://www.pnas.org/content/105/36/13556.full.pdf

T. Muraoka, J. Soh, S. Toyooka, Y. Maki, K. Shien et al., Impact of aberrant methylation of microRNA-9 family members on non-small cell lung cancers, Molecular and Clinical Oncology, vol.1, issue.1, pp.185-194
DOI : 10.3892/mco.2012.18

C. Simmons, F. Koinis, M. Fallon, K. Fearon, J. Bowden et al., Prognosis in advanced lung cancer?A prospective study examining key clinicopathological factors. Lung Cancer Amst Neth, pp.304-313, 2015.

C. Azzoli, S. Temin, and G. Giaccone, 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non???Small-Cell Lung Cancer, Journal of Oncology Practice, vol.8, issue.1, pp.63-69
DOI : 10.1200/JOP.2011.000374

S. Tabchi, E. Kassouf, M. Florescu, M. Tehfe, and N. Blais, Factors influencing treatment selection and survival in advanced lung cancer, Current Oncology, vol.24, issue.2, p.115, 2017.
DOI : 10.3747/co.24.3355
URL : http://www.current-oncology.com/index.php/oncology/article/download/3355/2397